5.1.1 | Deliver claimed performance safely | 0 |
5.1.2 | Run a risk management system across the life cycle | 1 |
5.1.3 | Apply risk control in the required order | 1 |
5.1.4 | Tell users about relevant residual risks | 1 |
5.1.5 | Lower risks that come from use and users | 1 |
5.1.6 | Hold performance over the expected life | 0 |
5.1.7 | Protect the device through transport and storage | 0 |
5.1.8 | Provide stability across shelf-life and use | 0 |
5.1.9 | Keep every known risk within acceptable limits | 1 |
5.10.1 | Device identification and user information | 0 |
5.11.1 | Radiation exposure reduction in design | 0 |
5.11.2 | Radiation instructions for users | 0 |
5.11.3 | Radiation emission warnings | 0 |
5.11.4 | Stray and scattered radiation control | 0 |
5.11.5 | Installation testing and maintenance instructions | 0 |
5.11.6 | Radiation output control and reproducibility | 0 |
5.12.1 | Lay user performance and instructions | 0 |
5.12.2 | Lay user safety and error reduction | 0 |
5.12.3 | Lay user self-check and failure alerts | 0 |
5.13.1 | Animal origin biological material safety | 0 |
5.13.2 | Regulatory duties for human origin materials | 0 |
5.13.3 | Other biological material safety | 0 |
5.2.1 | Base clinical evaluation on adequate data | 0 |
5.2.2 | Conduct clinical investigations with ethical safeguards | 0 |
5.3.1 | Characterise chemical, physical and biological properties | 0 |
5.3.2 | Minimise contaminants and residues | 0 |
5.3.3 | Limit release of substances and degradation products | 0 |
5.3.4 | Guard against unintended ingress | 0 |
5.3.5 | Design away infection and exposure hazards | 0 |
5.4.1 | Enable safe reprocessing by the user | 0 |
5.4.2 | Keep the labelled microbial condition | 0 |
5.4.3 | Supply sterile devices in undamaged packaging | 0 |
5.4.4 | Validate sterilisation and shelf-life for sterile devices | 0 |
5.4.5 | Make sterile products in controlled facilities | 0 |
5.4.6 | Package and validate for pre-use sterilisation | 0 |
5.4.7 | Tell sterile and non-sterile versions apart | 0 |
5.5.1 | Safety of device combinations and connections | 0 |
5.5.2 | Design for intended environment and use conditions | 0 |
5.5.3 | Fire and explosion risk reduction | 0 |
5.5.4 | Adjustment, calibration and maintenance done safely | 0 |
5.5.5 | Dependable interoperability with other devices | 0 |
5.5.6 | Reducing risk from unauthorised access | 0 |
5.5.7 | Ergonomic measurement and display scales | 0 |
5.5.8 | Safe disposal and recycling | 0 |
5.6.1 | Guarding against mechanical hazards | 0 |
5.6.2 | Reducing vibration risks | 0 |
5.6.3 | Reducing noise risks | 0 |
5.6.4 | Failure of parts that are reconnected | 0 |
5.6.5 | Safe surface temperatures | 0 |
5.7.1 | Single fault safety for active devices | 0 |
5.7.2 | Internal power supply status warning | 0 |
5.7.3 | Alarm for external power failure | 0 |
5.7.4 | Alarms for clinical parameters under monitoring | 0 |
5.7.5 | Containing electromagnetic interference | 0 |
5.7.6 | Adequate electromagnetic immunity | 0 |
5.7.7 | Protection from accidental electric shock | 0 |
5.8.1 | Safety and performance of device software | 0 |
5.8.2 | State of the art software lifecycle | 0 |
5.8.3 | Software on mobile computing platforms | 0 |
5.8.4 | Minimum IT requirements for software | 0 |
5.8.5 | Cybersecurity against unauthorised access | 0 |
5.9.1 | Accuracy of diagnostic and measuring functions | 0 |
6.1.1 | Material and tissue compatibility assessment | 0 |
6.1.2 | Safe contact with substances and medicinal products | 0 |
6.1.3 | Reducing risks from released particles | 0 |
6.2.1 | Imaging quality with minimal radiation exposure | 0 |
6.2.2 | Accurate treatment dose estimation and recording | 0 |
6.3.1 | Risks from treatment used with implants | 0 |
6.3.2 | Identification of programmable active implants | 0 |
6.4.1 | Accurate setting of delivered energy or substances | 0 |
6.4.2 | Preventing and indicating delivery inadequacies | 0 |
6.5.1 | Device incorporating an ancillary medicinal substance | 0 |
7.1.1 | IVD material compatibility and analytical performance | 0 |
7.2.1 | Stated analytical and clinical performance | 0 |
7.2.2 | Traceability of calibrator and control values | 0 |
7.2.3 | Standardised units for numerical results | 0 |
7.2.4 | Evaluation against the intended use statement | 0 |
APP-A | Using standards to show conformity | 0 |
APP-B | Guidance table for essential principles | 0 |
CL1 | Coverage and reasoned omissions | 0 |
CL2 | Reference documents and supporting standards | 0 |
CL3 | Defined terms used throughout the guidance | 0 |
CL4 | Overall structure of the essential principles | 0 |
INTRO | Purpose and conventions of harmonised essential principles | 0 |